Decheng Capital LLC
Source: SEC Form 13F · as of Mar 2026Decheng Capital LLC holds 7 biotech & pharma companies tracked by BioSniper, totaling $183.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$183.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Nuvation Bio Inc. (NUVB)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| NUVBNuvation Bio Inc. | 25,954,439 | $111.3M |
| UPBUpstream Bio, Inc. | 2,724,868 | $24.5M |
| AARDAardvark Therapeutics, Inc. | 3,917,299 | $14.8M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 325,057 | $10.4M |
| RCUSArcus Biosciences, Inc. | 477,819 | $10.3M |
| RVMDREVOLUTION MEDICINES, INC. | 93,500 | $9.1M |
| ZNTLZentalis Pharmaceuticals, Inc. | 1,323,327 | $3.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.